Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Fibroblastic foci, known to be the leading edge of fibrosis development in idiopathic pulmonary fibrosis (IPF), are composed of fibrogenic myofibroblasts. Autophagy has been implicated in the regulation of myofibroblast differentiation. Insufficient mitophagy, the mitochondria-selective autophagy, results in increased reactive oxygen species, which may modulate cell signaling pathways for myofibroblast differentiation. Therefore, we sought to investigate the regulatory role of mitophagy in myofibroblast differentiation as a part of IPF pathogenesis. Lung fibroblasts were used in in vitro experiments. Immunohistochemical evaluation in IPF lung tissues was performed. PARK2 was examined as a target molecule for mitophagy regulation, and a PARK2 knockout mouse was employed in a bleomycin-induced lung fibrosis model. We demonstrated that PARK2 knockdown-mediated mitophagy inhibition was involved in the mechanism for activation of the platelet-derived growth factor receptor (PDGFR)/PI3K/AKT signaling pathway accompanied by enhanced myofibroblast differentiation and proliferation, which were clearly inhibited by treatment with both antioxidants and AG1296, a PDGFR inhibitor. Mitophagy inhibition–mediated activation of PDGFR signaling was responsible for further autophagy suppression, suggesting the existence of a self-amplifying loop of mitophagy inhibition and PDGFR activation. IPF lung demonstrated reduced PARK2 with concomitantly increased PDGFR phosphorylation. Furthermore, bleomycin-induced lung fibrosis was enhanced in PARK2 knockout mice and subsequently inhibited by AG1296. These findings suggest that insufficient mitophagy-mediated PDGFR/PI3K/AKT activation, which is mainly attributed to reduced PARK2 expression, is a potent underlying mechanism for myofibroblast differentiation and proliferation in fibroblastic foci formation during IPF pathogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Pulmonary fibrosis | Whole‐body deletion of Prkn | Accelerated development of bleomycin‐induced lung fibrosis after mitophagy inhibition | Kobayashi et al (2016) |”
From Autophagy in major human diseases (2021) · cites this paper as Kobayashi et al (2016)
In the citing paper
“In accordance with this notion, genetic loss of Pink1 and Prkn accelerates the development of the fibrotic phenotype in bleomycin‐treated mice, linked to alveolar epithelial cell II (AECII) loss and accrued inflammation (Bueno et al, 2015; Kobayashi et al, 2016).”
From Autophagy in major human diseases (2021) · cites this paper as Kobayashi et al, 2016
Citations
Cites
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605 · cited 1×
“Yoshimori (Osaka University, Osaka, Japan) and was cloned into the pEGFP-C1 vector (21).”
MethodEfficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Autophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835 · cited 2×
“Both PINK1 and PARK2 are essential for mitophagy and mitochondrial ROS regulation (25).”
BackgroundKing, T. E., Pardo, A., & Selman, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60052-4 · Cited by 2,194
Rubinsztein, D. C., Mariño, G., & Kroemer, G. (2011) · Cell · doi:10.1016/j.cell.2011.07.030 · Cited by 2,107
Dynamics and diversity in autophagy mechanisms: lessons from yeast
Nakatogawa, H., Suzuki, K., Kamada, Y., & Ohsumi, Y. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2708 · Cited by 1,725
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 1×
“It has been reported that mitophagy inhibition by genetic deletion of PINK1 can be rescued by transgenic PARK2 expression, but not vice versa, indicating the pivotal role of PARK2 in mitophagy regulation (36).”
BackgroundPINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis
Bueno, M., Lai, Y.-C., Romero, Y., Brands, J., St. Croix, C. M., Kamga, C., Corey, C., Herazo-Maya, J. D., Sembrat, J., Lee, J. S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74942 · Cited by 627 · cited 4×
“with enhanced apoptosis in alveolar epithelial cells, which was involved in lung fibrosis development in BLM-treated PINK1 KO mice (18).”
BackgroundResultInfluential
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
The mitophagy pathway and its implications in human diseases
Wang, S., Long, H., Hou, L., Feng, B., Ma, Z., Wu, Y., Zeng, Y., Cai, J., Zhang, D.-W., & Zhao, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01503-7 · Cited by 883
“For fibroblasts, mitophagy is reduced during pulmonary fibrosis, leading to insufficient ROS clearance, the differentiation of myofibroblasts and the formation of fibroblast foci.(240,241) For type II alveolar epithelial cells, as IPF lungs age, the expression of PINK1 decreases, which causes mitochondrial swelling an…”
BackgroundMitochondria in health, disease, and aging
Harrington, J. S., Ryter, S. W., Plataki, M., Price, D. R., & Choi, A. M. K. (2023) · Physiological Reviews · doi:10.1152/physrev.00058.2021 · Cited by 602
Metformin reverses established lung fibrosis in a bleomycin model
Rangarajan, S., Bone, N. B., Zmijewska, A. A., Jiang, S., Park, D. W., Bernard, K., Locy, M. L., Ravi, S., Deshane, J., Mannon, R. B., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0087-6 · Cited by 560
Autophagy and inflammation in chronic respiratory disease
Racanelli, A. C., Kikkers, S. A., Choi, A. M. K., & Cloonan, S. M. (2018) · Autophagy · doi:10.1080/15548627.2017.1389823 · Cited by 547
“Targeting autophagy in IPF may offer therapeutic potential including the use of IL17A neutralizing antibodies,(106) MIR449A (microRNA 449a),(107) or PDGFRB (platelet derived growth factor receptor beta) inhibitors.(99) In addition, MAP1LC3B overxpression in vitro protects against the development of Hermansky-Pudlak sy…”
BackgroundMitochondrial quality control in kidney injury and repair
Tang, C., Cai, J., Yin, X.-M., Weinberg, J. M., Venkatachalam, M. A., & Dong, Z. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00369-0 · Cited by 513
Complex interplay between autophagy and oxidative stress in the development of pulmonary disease
Ornatowski, W., Lu, Q., Yegambaram, M., Garcia, A. E., Zemskov, E. A., Maltepe, E., Fineman, J. R., Wang, T., & Black, S. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101679 · Cited by 467
“PINK1 activates Parkin by phosphorylation and active Parkin ubiquitinates mitochondrial surface proteins, and the ubiquitinated mitochondria are then delivered to the autophagosome via p62, facilitating autophagic removal of the damaged mitochondria [171].”
BackgroundInfluentialMyofibroblasts and Fibrosis: Mitochondrial and Metabolic Control of Cellular Differentiation
Gibb, A. A., Lazaropoulos, M. P., & Elrod, J. W. (2020) · Circulation Research · doi:10.1161/circresaha.120.316958 · Cited by 434
Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
Mora, A. L., Rojas, M., Pardo, A., & Selman, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.170 · Cited by 402
Extracellular matrix in lung development, homeostasis and disease
Zhou, Y., Horowitz, J. C., Naba, A., Ambalavanan, N., Atabai, K., Balestrini, J., Bitterman, P. B., Corley, R. A., Ding, B.-S., Engler, A. J., et al. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.005 · Cited by 284
Role and Mechanisms of Mitophagy in Liver Diseases
Ma, X., McKeen, T., Zhang, J., & Ding, W.-X. (2020) · Cells · doi:10.3390/cells9040837 · Cited by 279
“Despite limited in vivo mitophagy studies likely due to the technical challenges, a few studies of mitophagy have been reported in mouse heart and muscle [98,99]; kidney [100]; lung [101] and neurons [102].”
BackgroundMitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis
Bueno, M., Calyeca, J., Rojas, M., & Mora, A. L. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101509 · Cited by 275
Oxidative Stress in Pulmonary Fibrosis
Otoupalova, E., Smith, S., Cheng, G., & Thannickal, V. J. (2020) · Comprehensive Physiology · doi:10.1002/cphy.c190017 · Cited by 262
“PARK2, a regulatory molecule of mitophagy, is reduced in IPF (280).”
Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis
Mora, A. L., Bueno, M., & Rojas, M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87440 · Cited by 235
Evolving and Expanding the Roles of Mitophagy as a Homeostatic and Pathogenic Process
Gustafsson, Å. B., & Dorn, G. W. (2019) · Physiological Reviews · doi:10.1152/physrev.00005.2018 · Cited by 228
Mitochondrial dysfunction in fibrotic diseases
Li, X., Zhang, W., Cao, Q., Wang, Z., Zhao, M., Xu, L., & Zhuang, Q. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00316-9 · Cited by 224
Mitochondrial quality control in pulmonary fibrosis
Larson-Casey, J. L., He, C., & Carter, A. B. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101426 · Cited by 189
“observed enhanced bleomycin-induced lung fibrosis in Park2 mice, no difference in type II AEC apoptosis was detected in these mice [49].”
BackgroundKadota, T., Fujita, Y., Araya, J., Watanabe, N., Fujimoto, S., Kawamoto, H., Minagawa, S., Hara, H., Ohtsuka, T., Yamamoto, Y., et al. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12124 · Cited by 187
“LFs were isolated and characterized as previously described (54) and 510 summarized here.”
Self-citationEmerging role of mitophagy in cardiovascular physiology and pathology
Morales, P. E., Arias-Durán, C., Ávalos-Guajardo, Y., Aedo, G., Verdejo, H. E., Parra, V., & Lavandero, S. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.09.006 · Cited by 178
Ryu, C., Sun, H., Gulati, M., Herazo-Maya, J. D., Chen, Y., Osafo-Addo, A., Brandsdorfer, C., Winkler, J., Blaul, C., Faunce, J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201612-2480oc · Cited by 171
“Interestingly, despite the distinct alterations in fibroblast metabolism caused by TGF-b1 (8, 9), as well as the demonstration of mitochondrial abnormalities as a driver of myofibroblast activation and experimentally induced lung fibrosis (20), an association of IPF with the extracellular accumulation of mtDNA has not…”
BackgroundGuan, R., Yuan, L., Li, J., Wang, J., Li, Z., Cai, Z., Guo, H., Fang, Y., Lin, R., Liu, W., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.02307-2021 · Cited by 167
“Previous reports have highlighted that the potential involvement of insufficient autophagy and mitophagy (mitochondria selective autophagy) in the pathogenesis of IPF through the regulation of fibroblast senescence and myofibroblast differentiation [13, 15].”
BackgroundMitochondrial dynamics and mitophagy in lung disorders
Sharma, A., Ahmad, S., Ahmad, T., Ali, S., & Syed, M. A. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119876 · Cited by 158
Role of Ferroptosis in Lung Diseases
Xu, W., Deng, H., Hu, S., Zhang, Y., Li, Z., Liu, M., Chen, Y., Wei, J., Yang, H., & Lv, X. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s307081 · Cited by 159
Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics
Zank, D. C., Bueno, M., Mora, A. L., & Rojas, M. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00010 · Cited by 150
Environmental Exposures and Asthma Development: Autophagy, Mitophagy, and Cellular Senescence
Sachdeva, K., Do, D. C., Zhang, Y., Hu, X., Chen, J., & Gao, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02787 · Cited by 147
Ryter, S. W., Rosas, I. O., Owen, C. A., Martínez, F. J., Choi, M. E., Lee, C. G., Elias, J. A., & Choi, A. M. K. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201808-585mg · Cited by 137
Cellular Senescence: Pathogenic Mechanisms in Lung Fibrosis
Parimon, T., Hohmann, M. S., & Yao, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126214 · Cited by 135
“Impairment of mitophagy mediated by Parkin deficiency in IPF lung fibroblasts has been associated with increased TGF-β-induced deposition of extracellular matrix [107].”
BackgroundInfluentialZhang, J., Wang, H., Chen, H., Li, H., Xu, P., Liu, B., Zhang, Q., Lv, C., & Song, X. (2022) · Autophagy · doi:10.1080/15548627.2022.2046448 · Cited by 126
“Targeting autophagy in IPF, including the use of IL17A (interleukin 17A) neutralizing antibodies [49], Mir449a [50], or PDGFRB (platelet derived growth factor receptor beta) inhibitors, may offer a therapeutic potential [51].”
BackgroundErratum: Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
Mora, A. L., Rojas, M., Pardo, A., & Selman, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.225 · Cited by 128
Autophagy, an important therapeutic target for pulmonary fibrosis diseases
Zhao, H., Wang, Y., Qiu, T., Liu, W., & Yao, P. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.12.016 · Cited by 115
PINK1-PARK2-mediated mitophagy in COPD and IPF pathogeneses
Tsubouchi, K., Araya, J., & Kuwano, K. (2018) · Inflammation and Regeneration · doi:10.1186/s41232-018-0077-6 · Cited by 120
Self-citationMitochondria Related Cell Death Modalities and Disease
Tian, C., Liu, Y., Li, Z., Zhu, P., & Zhao, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.832356 · Cited by 116
“(Kobayashi et al., 2016) used a mitophagy protein PARK2 knockout mouse model and found that mitochondrial autophagy was inhibited.”
MethodRegulation of the NLRP3 inflammasome by autophagy and mitophagy
Gupta, S., Cassel, S. L., Sutterwala, F. S., & Dagvadorj, J. (2024) · Immunological Reviews · doi:10.1111/imr.13410 · Cited by 132
“155 In addition, deficiency in PINK1 and Parkin were also shown to enhance myofibroblast differentiation and activate pro-fibrotic signaling pathways during IPF, 156,157 suggesting that mitophagy can play a protective role in IPF.”
The Aging Lung and Idiopathic Pulmonary Fibrosis
Gulati, S., & Thannickal, V. J. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.02.008 · Cited by 111
Pokharel, M. D., Flores, A. G., Marciano, D. P., Franco, M. C., Fineman, J. R., Aggarwal, S., Wang, T., & Black, S. M. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103049 · Cited by 138
“Mitophagy impairment induced by PINK1 deficiency is associated with increased extracellular matrix deposition, implicating mitochondria in the fibrogenesis process of IPF [190].”
BackgroundFibroblast Senescence in Idiopathic Pulmonary Fibrosis
Lin, Y., & Xu, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.593283 · Cited by 116
Mitochondrial Dysfunction in Pulmonary Fibrosis
Rangarajan, S., Bernard, K. F., & Thannickal, V. J. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201705-370aw · Cited by 116
Kurita, Y., Araya, J., Minagawa, S., Hara, H., Ichikawa, A., Saito, N., Kadota, T., Tsubouchi, K., Sato, N., Yoshida, M., et al. (2017) · Respiratory Research · doi:10.1186/s12931-017-0600-3 · Cited by 98
“Recent papers, including our findings, propose a role for the accumulation of mitochondrial ROS in IPF pathogenesis due to impaired mitophagy [20, 27].”
BackgroundMethodSelf-citationFibrometabolism—An emerging therapeutic frontier in pulmonary fibrosis
Selvarajah, B., Azuelos, I., Anastasiou, D., & Chambers, R. C. (2021) · Science Signaling · doi:10.1126/scisignal.aay1027 · Cited by 104
“It has also been shown that knockdown of both PINK1 or Prkn in lung fibroblasts causes a decrease in mitophagy, leading to mtROS production and promoting signaling through the profibrotic platelet-derived growth factor (PDGF), which drives increased fibroblast proliferation and myofibroblast differentiation (80).”
BackgroundTsubouchi, K., Araya, J., Minagawa, S., Hara, H., Ichikawa, A., Saito, N., Kadota, T., Sato, N., Yoshida, M., Kurita, Y., et al. (2017) · Autophagy · doi:10.1080/15548627.2017.1328348 · Cited by 103
“Western blotting was performed as described previously.(23) For each experiment, equal amounts of total protein were resolved by 7.”
BackgroundMethodSelf-citationZhou, W., Qu, J., Xie, S.-Y., Sun, Y., & Yao, H.-W. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5188306 · Cited by 104
“This is associated with increased mtROS production and activation of the platelet-derived growth factor receptor (PDGFR)/PI3K/AKT signaling pathway, resulting in increased myofibroblast differentiation and proliferation for fibrotic foci formation [176].”
BackgroundHosseinzadeh, A., Javad-Moosavi, S. A., Reiter, R. J., Yarahmadi, R., Ghaznavi, H., & Mehrzadi, S. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1541318 · Cited by 94
“protein encoded by the PARK2 gene) for mitophagy clearance [97].”
BackgroundInvolvement of GPx4-Regulated Lipid Peroxidation in Idiopathic Pulmonary Fibrosis Pathogenesis
Tsubouchi, K., Araya, J., Yoshida, M., Sakamoto, T., Koumura, T., Minagawa, S., Hara, H., Hosaka, Y., Ichikawa, A., Saito, N., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801232 · Cited by 96
“In our previous report, we showed that mitochondrial ROS production was involved in myofibroblast differentiation and proliferation through activating platelet-derived growth factor receptor (PDGFR) signaling in terms of IPF pathogenesis (49).”
BackgroundSelf-citationRegulated Necrosis in Pulmonary Disease. A Focus on Necroptosis and Ferroptosis
Minagawa, S., Yoshida, M., Araya, J., Hara, H., Imai, H., & Kuwano, K. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0337tr · Cited by 97
Self-citationExtracellular Vesicles in Chronic Obstructive Pulmonary Disease
Kadota, T., Fujita, Y., Yoshioka, Y., Araya, J., Kuwano, K., & Ochiya, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111801 · Cited by 90
“Recently, we also reported that the insufficient mitophagy-mediated activation of the platelet-derived growth factor receptor (PDGFR)/phosphoinositide 3-kinase (PI3K)/AKT pathway, which is mainly attributed to reduced parkin RBR E3 ubiquitin protein ligase (PARK2) expression, is a potent underlying mechanism for myofi…”
BackgroundSelf-citationManevski, M., Muthumalage, T., Devadoss, D., Sundar, I. K., Wang, Q., Singh, K. P., Unwalla, H. J., Chand, H. S., & Rahman, I. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101443 · Cited by 92
Mitochondrial Quality Control in COPD and IPF
Hara, H., Kuwano, K., & Araya, J. (2018) · Cells · doi:10.3390/cells7080086 · Cited by 84
“ROS activates PDGF receptors and downstream Akt and mTOR, leading to increased proliferation of fibroblasts and myofibroblast differentiation [19].”
BackgroundSelf-citationAutophagy in Pulmonary Diseases
Nakahira, K., Pabon Porras, M. A., & Choi, A. M. K. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2468so · Cited by 78
Protective Features of Autophagy in Pulmonary Infection and Inflammatory Diseases
Wang, K., Chen, Y., Zhang, P., Lin, P., Xie, N., & Wu, M. (2019) · Cells · doi:10.3390/cells8020123 · Cited by 77
“PARK2 deficiency aggravates bleomycin–induced pulmonary fibrosis in mice through promoting PDGFR-PI3K-Akt-mediated myofibroblast differentiation and proliferation [93].”
BackgroundAhangari, F., Price, N. L., Malik, S., Chioccioli, M., Bärnthaler, T., Adams, T. S., Kim, J., Pradeep, S. P., Ding, S., Cosmos, C., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.158100 · Cited by 70
“Insufficient mitophagy gives rise to the accumulation of damaged mitochondria, and it is implicated in a cell-specific manner in the pathogenesis of IPF (35, 50, 51).”
Benchmarking a highly selective USP30 inhibitor for enhancement of mitophagy and pexophagy
Rusilowicz-Jones, E. V., Barone, F. G., Lopes, F. M., Stephen, E., Mortiboys, H., Urbé, S., & Clague, M. J. (2021) · Life Science Alliance · doi:10.26508/lsa.202101287 · Cited by 73
“Thus inhibition of USP30 represents an actionable target to correct pathologies associated with PINK1 or Parkin defects, such as Parkinson’s disease or pulmonary fibrosis [7, 8].”
Self-eating: friend or foe? The emerging role of autophagy in fibrotic diseases
Li, Y., Liu, R., Wu, J., & Li, X. (2020) · Theranostics · doi:10.7150/thno.47826 · Cited by 71
“Genetic deletion of PARK2 inhibited mitophagy and enhanced myofibroblast differentiation and proliferation by activating the PDGFR-PI3K-Akt pathway in the BLM-induced mouse model [103].”
BackgroundThe potential role of necroptosis in clinical diseases (Review)
Dai, W., Cheng, J. Q., Leng, X., Hu, X., & Ao, Y. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4922 · Cited by 74
“Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic lung disease characterized by the usual interstitial pneumonia pattern at histopathologic examination (98).”
BackgroundEpithelial-stromal crosstalk and fibrosis in eosinophilic esophagitis
Muir, A. B., Wang, J. X., & Nakagawa, H. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1498-3 · Cited by 74
“Impaired Parkin-mediated mitophagy may have a role in the pathogenesis of pulmonary fibrosis [77].”
BackgroundLuo, X., Xu, Z.-X., Wu, J.-C., Luo, S.-Z., & Xu, M.-Y. (2021) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2021.10.022 · Cited by 64
Ding, Q., Xie, X.-L., Wang, M.-M., Yin, J., Tian, J.-M., Jiang, X.-Y., Zhang, D., Han, J., Bai, Y., Cui, Z.-J., et al. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0199-6 · Cited by 60
Tsitoura, E., Vasarmidi, E., Bibaki, E., Trachalaki, A., Koutoulaki, C., Papastratigakis, G., Papadogiorgaki, S., Chalepakis, G., Tzanakis, N., & Antoniou, K. M. (2019) · Respiratory Research · doi:10.1186/s12931-019-1196-6 · Cited by 66
“PARK2 knockdown induces mitochondrial damage, increases mtROS production and promotes fibrosis through enhancement of apoptotic resistant phenotype of fibroblasts and myofibroblast differentiation [13].”
BackgroundWang, W., Zhang, Y., Huang, W., Yuan, Y., Hong, Q., Xie, Z., Li, L., Chen, Y., Li, X., & Meng, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-022-03837-2 · Cited by 66
“Reduced expression of Parkin and LC3B, two of the crucial factors in this process, indicates insufficient mitophagy in activated fibroblasts [39, 40].”
BackgroundMetabolic Disorders in Chronic Lung Diseases
Παπαϊωάννου, Ο., Karampitsakos, Τ., Barbayianni, I., Chrysikos, S., Xylourgidis, N., Tzilas, V., Bouros, D. E., Aidinis, V., & Tzouvelekis, A. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2017.00246 · Cited by 61
The mitochondria in lung fibrosis: friend or foe?
Malsin, E. S., & Kamp, D. W. (2018) · Translational research · doi:10.1016/j.trsl.2018.05.005 · Cited by 58
“A prominent pathophysiological role for PARK2 deficiency in the lungs of patients with IPF has also been recently suggested and that reduced PARK2 expression occurs in association with activation of the PDGFR receptor.(123) Consistent with this hypothesis, PARK2-deficient mice are more susceptible to bleomycin-induced…”
BackgroundUSP30: Structure, Emerging Physiological Role, and Target Inhibition
Wang, F., Gao, Y. P., Zhou, L., Chen, J., Xie, Z., Ye, Z., & Wang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.851654 · Cited by 63
“Thus, inhibition of USP30 may represent an actionable target to correct the PINK1/Parkin defect-associated pathologies of pulmonary fibrosis (Kobayashi et al., 2016) (Table 1).”
BackgroundJankauskas, S. S., Mone, P., Avvisato, R., Varzideh, F., Gennaro, S. D., Salemme, L., Macina, G., Kansakar, U., Cioppa, A., Frullone, S., et al. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111818 · Cited by 54
Mitochondrial Quality Control in Age-Related Pulmonary Fibrosis
Roque, W., Cuevas-Mora, K., & Romero, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020643 · Cited by 46
“reported that impaired mitophagy by Parkin deficiency induces activation of platelet-derived growth factor receptor (PDGFR)/mammalian target of rapamycin (mTOR) signaling, prompting differentiation and proliferation of myofibroblast [57].”
BackgroundAir Pollution—An Overlooked Risk Factor for Idiopathic Pulmonary Fibrosis
Majewski, S., & Piotrowski, W. J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010077 · Cited by 53
Autophagy in pulmonary fibrosis: friend or foe?
Hill, C. N., & Wang, Y. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.09.008 · Cited by 52
“Park2 / mice exhibited reduced mitophagy and increased FMT mediated by the activation of the platelet-derived growth factor receptor (PDGFR)-P13KAkt pathway upon BLM-treatment.(107) A recent study demonstrated a role for phosphoglycerate mutase family member 5 (PGAM5) in the pathogenesis of IPF.”
Kim, S.-J., Cheresh, P., Jablonski, R. P., Rachek, L. I., Yeldandi, A. V., Aillon, R. P., Ciesielski, M., Ridge, K. M., Gottardi, C. J., Lam, A. P., et al. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00069.2019 · Cited by 48
Gong, H., Lyu, X., Liu, Y., Peng, N., Tan, S., Dong, L., & Zhang, X. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122218 · Cited by 40
Mitochondrial quality control in lung diseases: current research and future directions
Liu, J., Wang, J., Xiong, A., Zhang, L., Zhang, Y., Liu, Y., Xiong, Y., Li, G., & He, X. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1236651 · Cited by 42
Mitochondrial biology in airway pathogenesis and the role of NRF2
Cho, H., & Kleeberger, S. R. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01182-5 · Cited by 44
Mansour, H. H., Omran, M. M., Hasan, H. F., & kiki, S. M. E. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13378 · Cited by 40
Role of autophagy in lung diseases and ageing
Zhang, Y., Zhang, J., & Fu, Z. (2022) · European Respiratory Review · doi:10.1183/16000617.0134-2022 · Cited by 42
Ruan, F., Wu, L., Yin, H., Fang, L., Tang, C., Huang, S., Fang, L., Zuo, Z., He, C., & Huang, J. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.117028 · Cited by 38
Role of cellular senescence in inflammatory lung diseases
Xie, C. H., Yalikun, M., Luo, Q., & Dong, J. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.02.001 · Cited by 33
Endometrial organoids: a reservoir of functional mitochondria for uterine repair
Hwang, S., Lee, D., Lee, G., Ahn, J., Lee, Y., Koo, H. S., & Kang, Y. (2024) · Theranostics · doi:10.7150/thno.90538 · Cited by 36
“Whereas the loss of mitochondrial biogenic function, fusion, and fission in damaged mitochondria at chronic state of inflammation occurred during 14-21 days after AS-induction might lead the low level of mitochondrial function-related gene expressions [61-63].”
BackgroundWu, Q., Xu, T., Liu, Y., Li, Y., Yuan, J., Yao, W., Xu, Q., Yan, W., & Ni, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112357 · Cited by 33
“Mitophagy appears to be involved in the development of several lung diseases, such as idiopathic pulmonary fibrosis (IPF) [4,5], chronic obstructive pulmonary disease (COPD) [6], and pulmonary hypertension (PH) [7].”
InfluentialAdhikari, M., Biswas, C., Mazumdar, P., Sarkar, S., & Pramanick, K. (2024) · NanoImpact · doi:10.1016/j.impact.2024.100507 · Cited by 39
Beclin 1, LC3, and p62 expression in paraquat-induced pulmonary fibrosis
Xu, G., Wang, X., Yu, H., Wang, C., Liu, Y., Zhao, R., & Zhang, G. (2019) · Human & Experimental Toxicology · doi:10.1177/0960327119842633 · Cited by 32
Double-edged mitophagy: balancing inflammation and resolution in lung disease
Tian, S., Zhang, Y., Liu, C. X., Zhang, H., Lu, Q., Zhao, Y., & Fan, H. (2025) · Clinical Science · doi:10.1042/cs20256705 · Cited by 41
“Similarly, Parkin overexpression in heat stroke models improves AEC survival by restoring mitophagy flux and mitochondrial integrity, whereas Parkin knockout amplifies ROS-driven PDGFR-PI3K-AKT signaling [131–134].”
Autophagy in chronic lung disease
Racanelli, A. C., Choi, A. M. K., & Choi, M. E. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.02.001 · Cited by 32
Zhang, Z., Zhang, C., Shao, B., Pang, D.-H., Han, G., & Li, L. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.04.029 · Cited by 29
Role of chaperone-mediated autophagy in the pathophysiology including pulmonary disorders
Hosaka, Y., Araya, J., Fujita, Y., & Kuwano, K. (2021) · Inflammation and Regeneration · doi:10.1186/s41232-021-00180-9 · Cited by 27
Self-citationInteractions of Autophagy and the Immune System in Health and Diseases
Pant, A., Yao, X., Lavedrine, A., Viret, C., Dockterman, J., Chauhan, S. C., Shi, C.-S., Manjithaya, R. R., Cadwell, K., Kufer, T. A., et al. (2022) · Autophagy Reports · doi:10.1080/27694127.2022.2119743 · Cited by 32
Cala-García, J., Medina-Rincón, G. J., Sierra-Salas, P. A., Rojano, J., & Romero, F. (2023) · Biology · doi:10.3390/biology12091237 · Cited by 28
“It has been demonstrated in animal models that insufficient mitophagy in the fibroblastic foci could potentially be explained by a PARK2-mediated platelet-derived growth factor receptor signaling pathway, which leads to an enhanced myofibroblast differentiation and proliferation [54].”
Kumari, S., Singh, P., & Singh, R. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111272 · Cited by 22
Kumari, S., Singh, P., Dash, D., & Singh, R. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101943 · Cited by 21
Mercader, J., Martín-Medina, A., Truyols-Vives, J., Escarrer-Garau, G., Elowsson, L., Montes‐Worboys, A., Río, C., Muncunill, J., Velasco-Roca, J., Cederberg, A., et al. (2023) · Cells · doi:10.3390/cells12162084 · Cited by 20
“These results suggest that IPF LRSMC may not activate mitochondrial respiration and turnover upon a profibrotic environment and are in accordance with the insufficient mitophagy occurring in myofibroblast differentiation [35,46].”
Expression of PINK1 and Parkin in human apical periodontitis
Liu, B., Zhang, J., Liu, G., Zhu, L., & Peng, B. (2022) · International Endodontic Journal · doi:10.1111/iej.13760 · Cited by 18
Mitochondrial dysfunction in fibrotic diseases: Research progress and MSC-exos therapy
Zhang, X., Wang, Y., Guo, X., Xiao, Y., Wan, W., Zou, H., & Yang, X. (2025) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2025.104983 · Cited by 18
Zhou, J., Song, Y., Wang, X., Li, X., Liu, C., Tian, C., Wang, C., Li, L., Yan, G., & Cui, H. (2023) · Pharmaceuticals · doi:10.3390/ph16101444 · Cited by 17
“Kobayashi et al. [34] observed a decrease in perox-isome proliferator-activated receptor gamma coactivator 1-alpha in IPF, which, in turn, amplified the signals associated with cellular contraction, matrix synthesis, fibroblast activation, and aging-related gene expression, leading to fibroblast…”
BackgroundEffects of Mitophagy on Regulatory T Cell Function in Patients With Myasthenia Gravis
Wang, N., Jiang, Y., Karim, M. R., Zhong, P., Sun, Y.-P., Zhang, H.-Y., & Wang, Y.-F. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00238 · Cited by 19
Parkin: A targetable linchpin in human malignancies
Perwez, A., Wahabi, K., & Rizvi, M. M. A. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188533 · Cited by 18
Vasarmidi, E., Sarantoulaki, S., Trachalaki, A., Margaritopoulos, G. A., Bibaki, E., Spandidos, D. A., Tzanakis, Ν., & Antoniou, K. M. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9356 · Cited by 17
“Similarly, PARKIN deficiency enhanced myofibroblast differentiation and pro‐fibrotic signaling (32).”
BackgroundTGF-β-induced CCR8 promoted macrophage transdifferentiation into myofibroblast-like cells
Liu, H., Guan, Q., Zhao, P., & Li, J. (2022) · Experimental Lung Research · doi:10.1080/01902148.2022.2055227 · Cited by 18
Galantamine ameliorates hyperoxia-induced brain injury in neonatal mice
Zaghloul, N., Cohen, N. S., Ayasolla, K., Li, H.-L., Kurepa, D., & Ahmed, M. N. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.890015 · Cited by 15
“The ROS levels in the samples was determined by comparison with the predetermined DCF standard curve (Kobayashi et al., 2016).”
MethodQi, L. I. N., Yating, L. I. N., Xinyan, L. I. A. O., Ziyi, C. H. E. N., Mengmeng, D. E. N. G., & Zhong, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-78136-5 · Cited by 22
Understanding the molecular regulatory mechanisms of autophagy in lung disease pathogenesis
Lin, L., Lin, Y., Han, Z., Wang, K., Zhou, S., Wang, Z., Wang, S., & Chen, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1460023 · Cited by 14
High‐altitude hypoxia‐induced rat alveolar cell injury by increasing autophagy
Zhao, Z., Hou, B., Tang, L., Wang, Y., Zhang, Y., Ying, Z., & Duo, J. (2022) · International Journal of Experimental Pathology · doi:10.1111/iep.12434 · Cited by 11
Zhou, Y., Su, W., Xu, M.-Z., Zhang, A., Li, S., Guo, H., Gong, K., Lu, K., Yu, X., Zhu, J., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119568 · Cited by 10
Aging and lung diseases: Unraveling mechanisms and therapeutic targets
Zhou, Y., Chen, G., Li, X., Li, X., Lin, Z., Liu, L., Pu, D., Chen, J., Chen, Y., Lin, Z., et al. (2025) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2025.11.005 · Cited by 11
Wanas, H., Elbadawy, H. M., Almikhlafi, M. A., Hamoud, A., Ali, E. N., & Galal, A. M. (2023) · Pharmaceuticals · doi:10.3390/ph16050697 · Cited by 10
“Mitophagy has been implicated in myofibroblast differentiation by regulating mitochondrial ROS-mediated platelet-derived growth factor receptor (PDGFR) activation [69].”
Background
Metadata
- Authors
- Kobayashi, K., Araya, J., Minagawa, S., Hara, H., Saito, N., Kadota, T., Sato, N., Yoshida, M., Tsubouchi, K., Kurita, Y., Ito, S., Fujita, Y., Takasaka, N., Utsumi, H., Yanagisawa, H., Hashimoto, M., Wakui, H., Kojima, J., Shimizu, K., Numata, T., Kawaishi, M., Kaneko, Y., Asano, H., Yamashita, M., Odaka, M., Morikawa, T., Nakayama, K., & Kuwano, K.
- Affiliations
- Jikei University School of Medicine (JP)
- Corresponding author
- Araya, Jun
- ORCID
- Kobayashi, Kenji
- Araya, Jun
- Minagawa, Shunsuke
- Hara, Hiromichi
- Saito, Nayuta
- Kadota, Tsukasa
- Sato, Nahoko
- Yoshida, Masahiro
- Tsubouchi, Kazuya
- Ito, Saburo
- Fujita, Yu
- Takasaka, Naoki
- Utsumi, Hirofumi
- Yanagisawa, Haruhiko
- Hashimoto, Mitsuo
- Numata, Takanori
- Asano, Hisatoshi
- Yamashita, Makoto
- Odaka, Makoto
- Nakayama, Katsutoshi
- Kuwano, Kazuyoshi
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-07
- Volume
- 197
- Issue
- 2
- Pages
- 504-516
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2414956908
- Cited by
- 145
- References
- 37
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 14 · 2023: 16 · 2022: 12 · 2021: 18 · 2020: 20 · 2019: 13 · 2018: 13 · 2017: 10 · 2016: 2
- FWCI
- 11.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Washington
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, mitophagy, PARK2, myofibroblast differentiation, fibroblastic foci, autophagy, reactive oxygen species, bleomycin-induced lung fibrosis, AG1296, antioxidants, lung fibroblasts
- MeSH terms
- Animals, Cell Differentiation, Fluorescent Antibody Technique, Humans, Immunohistochemistry, Blotting, Western, Signal Transduction, Receptors, Platelet-Derived Growth Factor, Mice, Knockout, Phosphatidylinositol 3-Kinases, In Situ Nick-End Labeling, Ubiquitin-Protein Ligases, Microscopy, Electron, Transmission, Proto-Oncogene Proteins c-akt, Mice, Idiopathic Pulmonary Fibrosis, Myofibroblasts, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.